Sucampo Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript

  • download
  • Print
  • Recommend
  • 0

2008-11-12 19:16:13.0

Tags: Revenue, Dr., Call Transcript, Earnings, Caris & Co., Sucampo Pharmaceuticals Inc., Safety Expansion, Operational Accounting, Finance, Seeking Alpha, Revenue, Dr., Call Transcript, Earnings, Caris & Co., Sucampo Pharmaceuticals Inc., Safety Expansion, Operational Accounting, Finance, Seeking Alpha

Question-and-Answer Session

Operator

(Operator Instructions). Your first question comes from the line of David Moscowitz from Caris. Please proceed.

David Moscowitz - Caris & Company

Thanks. Good evening, everyone. Question about the OBD revenue deferment; it sounds to me like the trials are still on track and yet you are deferring that revenue. I don’t quite understand what happened in the quarter with that?

Jan Smilek

This is Jan. What we have done, as you may remember from the first and second quarter, at the beginning of the second quarter, we have actually have changed the estimate when that trial is going to be completed. And that change resulted in the deferral in that month, but he deferral actually continues until we hit from an accounting point if we hit a cumulative expenses that are going to be higher than a straight line cumulative expenses that are resulting from that change in estimates. So, we believe that we are going to continue to defer some revenue until probably through early first quarter of 2009 and at that moment the revenue will start to be utilized and as I said, most of that revenue is going to be utilized in the second quarter of 2009, or just second half of 2009.

David Moscowitz - Caris & Company

Just to confirm: I thought I heard Dr. Ueno say is the results from OBD would be available on mid-2009.

Stan Miele

Lead from the two pivotal studies and we have also a safety expansion, but I will let Dr. Ueno to address that.

Dr. Ryuji Ueno

I am talking about the two pivotal data that will be available sometime in the middle of next year, but safety expansion is to continue.

David Moscowitz - Caris & Company

So the safety expansion is going to continue potentially until late September?

Dr. Ryuji Ueno

Yes. Late September.

David Moscowitz - Caris & Company

Okay. And could you give us the reported revenues of AMITIZA by Takeda in US dollars, please?

Jan Smilek

Takeda reported their six months revenue. Their fiscal year-end starts on April 1st and for the first six months they've reported $100 million in that revenue.

David Moscowitz - Caris & Company

That’s in dollars?

Jan Smilek

Yes.

David Moscowitz - Caris & Company

Okay, but they are off counters, is that correct?

Jan Smilek

Their fiscal year ends on March 31st.

David Moscowitz - Caris & Company

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here